Cagent Vascular, Inc. announced a Series C Financing close in excess of $30M led by U.S. Venture Partners (USVP). New investor Blue Ridge Medical, LLC and existing investors, including Sectoral Asset Management, also participated in the funding round.
Who to call at Cagent Vascular, and when
A new round usually means Cagent Vascular is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cagent Vascular
Location
150 STRAFFORD AVENUE
Wayne, Pennsylvania, United States
About
Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cagent Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WayneHealthcareHealth Care